cephalosporin c has been researched along with Infectious Diseases in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (25.00) | 18.7374 |
| 1990's | 2 (8.33) | 18.2507 |
| 2000's | 7 (29.17) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 9 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Aitken, SL; Bonomo, RA; Clancy, CJ; Mathers, AJ; Tamma, PD; van Duin, D | 1 |
| Franco, S; Hammerschlag, MR; Mesa, D; Rampersad, D | 1 |
| Bruno, C; Dillon, RJ; Khankhel, ZS; Puzniak, L; Thosar, M | 1 |
| Liu, S; Lopes, B; Patil, S; Wagh, K; Wen, F | 1 |
| Stamm, P; Urmann, E; Wisskirchen, J | 1 |
| Asoyan, V; Gyulazyan, N; Hashmi, MF; Khan, F; Mkhoyan, A; Nersisyan, V | 1 |
| Cantón, R; Ruiz-Garbajosa, P | 1 |
| Goda, K; Hashimoto, H; Hatakeyama, S; Kitsuregawa, M; Mitsutake, N; Nagai, R; Saito, M; Sato, J | 1 |
| Powers, JH | 1 |
| Akimoto, S; Hotta, T; Iwakura, S; Johata, K; Kobayasi, Y; Kontani, T; Masaki, K; Noguchi, K; Ochiai, M; Onishi, H; Sahara, M; Tanimura, H; Uchiyama, K | 1 |
| Blanca, M; Juarez, C; Mayorga, C; Montañez, MI; Perez-Inestrosa, E; Suau, R; Torres, MJ | 1 |
| Atanasković-Marković, M; Cirković Velicković, T; Gavrović-Jankulović, M; Ivanovski, P; Nestorović, B | 1 |
| Ferrero, R; Pavesio, D; Pecco, P; Viretto, A | 1 |
| Holbrook, KA; Lowy, FD | 1 |
| Almela, M; García San Miguel, J; Marco, F; Martínez, JA; Mensa, J; Moreno-Martínez, A; Soriano, E; Vila, J | 1 |
| Burgmann, H; Hörl, WH; Rosenkranz, AR; Schmaldienst, S; Thalhammer, F; Thalhammer-Scherrer, R; Traunmüller, F | 1 |
| Kallio, MJ; Peltola, H; Vuori-Holopainen, E | 1 |
| Ahmed, F; Wasti, S | 1 |
| Perry, TR; Schentag, JJ | 1 |
| Perlman, D | 1 |
| Plotkin, SA | 1 |
| Kaplan, K; Weinstein, L | 1 |
| Helwig, H; Hueppchen, C; Kunz, H | 1 |
| Stewart, GT | 1 |
6 review(s) available for cephalosporin c and Infectious Diseases
| Article | Year |
|---|---|
Ceftolozane/tazobactam for the treatment of bacteremia: a systematic literature review (SLR).
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Communicable Diseases; Humans; Tazobactam | 2022 |
Treatment guidelines for multidrug-resistant Gram-negative microorganisms.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Cephalosporins; Communicable Diseases; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests | 2023 |
Immediate allergic reactions to betalactams: facts and controversies.
Topics: Anti-Bacterial Agents; Cephalosporins; Communicable Diseases; Cross Reactions; Drug Hypersensitivity; Humans; Hypersensitivity, Immediate; Lactams; Penicillins | 2004 |
Beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cephalosporins; Communicable Diseases; Humans; Penicillins | 1998 |
Clinical use of ceftriaxone: a pharmacokinetic-pharmacodynamic perspective on the impact of minimum inhibitory concentration and serum protein binding.
Topics: Adult; Aged; Area Under Curve; Ceftriaxone; Cephalosporins; Child; Communicable Diseases; Half-Life; Humans; Microbial Sensitivity Tests; Protein Binding | 2001 |
The cephalosporins. Microbiological, chemical, and pharmacological properties and use in chemotherapy of infection.
Topics: Acremonium; Aminohydrolases; Animals; Cephaloridine; Cephalosporins; Cephalothin; Chemical Phenomena; Chemistry; Communicable Diseases; Drug Hypersensitivity; Humans; Infections; Kidney Diseases; Penicillin Resistance; Salmonella Infections; Staphylococcal Infections | 1970 |
3 trial(s) available for cephalosporin c and Infectious Diseases
| Article | Year |
|---|---|
Study of the absorption of cefcapene pivoxil in patients with infectious disease and soft stool or diarrhea.
Topics: Absorption; Adult; Aged; Aged, 80 and over; Cephalosporins; Communicable Diseases; Diarrhea; Feces; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Treatment Outcome; Urine | 2003 |
[Cefixime versus amoxicillin plus netilmicin in the treatment of community-acquired non-complicated acute pyelonephritis].
Topics: Acute Disease; Adult; Aged; Amoxicillin; Bacteremia; Cefixime; Cefotaxime; Cephalosporins; Communicable Diseases; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Netilmicin; Pyelonephritis | 1998 |
Narrow- versus broad-spectrum parenteral anatimicrobials against common infections of childhood: a prospective and randomised comparison between penicillin and cefuroxime.
Topics: Adolescent; Cefuroxime; Cephalosporins; Child; Child, Preschool; Communicable Diseases; Female; Humans; Infant; Male; Penicillin G Procaine; Penicillins; Prospective Studies | 2000 |
15 other study(ies) available for cephalosporin c and Infectious Diseases
| Article | Year |
|---|---|
Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Carbapenems; Cephalosporins; Child; Communicable Diseases; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; United States | 2022 |
Treatment options for neonatal infections in the post-cefotaxime era.
Topics: Ampicillin; Anti-Bacterial Agents; Calcium; Cefepime; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Communicable Diseases; Gentamicins; Humans; Infant, Newborn; Infant, Newborn, Diseases; Microbial Sensitivity Tests | 2022 |
ESBL encoding third-generation cephalosporin resistance observed in bloodstream infection in India.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Communicable Diseases; Escherichia coli Infections; Humans; India; Microbial Sensitivity Tests; Sepsis | 2023 |
[Cefiderocol in AML patient with neutropenic infection due to 4MRGN Klebsiella pneumoniae (VIM-1)].
Topics: Aged; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Cefiderocol; Ceftazidime; Cephalosporins; Colistin; Communicable Diseases; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Neoplasm Recurrence, Local; Neutropenia | 2023 |
Stevens-Johnson syndrome: a case report of possible cephalosporin-induced cutaneous adverse reaction.
Topics: Cephalosporins; Communicable Diseases; Female; Humans; Middle Aged; Skin; Stevens-Johnson Syndrome | 2023 |
Indications and classes of outpatient antibiotic prescriptions in Japan: A descriptive study using the national database of electronic health insurance claims, 2012-2015.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antimicrobial Stewardship; Cephalosporins; Child; Child, Preschool; Communicable Diseases; Databases, Factual; Drug Prescriptions; Female; Humans; Infant; Infant, Newborn; Insurance, Health; Japan; Macrolides; Male; Middle Aged; Outpatients; Pharyngitis; Quinolones; Respiratory Tract Infections; Sinusitis; Young Adult | 2020 |
Scientific Evidence, Regulatory Decision Making, and Incentives for Therapeutics in Infectious Diseases: The Example of Cefiderocol.
Topics: Cefiderocol; Cephalosporins; Communicable Diseases; Decision Making; Humans; Microbial Sensitivity Tests; Motivation; United States; United States Food and Drug Administration | 2021 |
A case of selective IgE-mediated hypersensitivity to ceftibuten.
Topics: Anaphylaxis; Ceftibuten; Cephalosporins; Child, Preschool; Communicable Diseases; Ear Diseases; Female; Humans; Immunoglobulin E; Skin Tests | 2005 |
[The use of cefotaxime in pediatrics: clinical and bacteriological experience].
Topics: Cefotaxime; Cephalosporins; Child; Child, Preschool; Communicable Diseases; Female; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Male | 1980 |
Multiple-dose pharmacokinetics of cefepime in long-term hemodialysis with high-flux membranes.
Topics: Adult; Cefepime; Cephalosporins; Communicable Diseases; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 2000 |
Infectious complications following abdominal hysterectomy in Karachi, Pakistan.
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Cefazolin; Cephalosporins; Communicable Diseases; Female; Humans; Hysterectomy; Laparotomy; Metronidazole; Middle Aged; Pakistan; Postoperative Complications; Prevalence; Retrospective Studies; Risk Factors; Surgical Wound Infection | 2001 |
Antimicrobial agents and chemotherapy.
Topics: Anti-Bacterial Agents; Cephalosporins; Chicago; Communicable Diseases; Genetic Code; Microbiology; Penicillins; Pseudomonas; Streptovaricin; United States | 1968 |
Antibiotics 1973.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Cephalosporins; Clindamycin; Communicable Diseases; Gonorrhea; Humans; Infant, Newborn; Infant, Newborn, Diseases; Penicillin Resistance; Penicillins; Research; United States; Urinary Tract Infections | 1973 |
Effectiveness and tolerance of cephalexin in children.
Topics: Administration, Oral; Adolescent; Cephalexin; Cephalosporins; Child; Child, Preschool; Communicable Diseases; Drug Tolerance; Humans; Infant; Infant, Newborn; Lung Diseases; Pyelonephritis | 1972 |
Steroid antibiotics.
Topics: Animals; Cephalosporins; Communicable Diseases; Dogs; Fusidic Acid; Guinea Pigs; Humans; Mice; Rats; Staphylococcal Infections | 1964 |